JAMA summit report outlines multilevel strategy for obesity care and prevention
A JAMA summit report highlights that while GLP-1 receptor agonists offer new opportunities, curbing obesity requires addressing broad structural, societal, and clinical barriers. Obesity affects more than 1 billion people worldwide, including nearly half of US adults and 1 in 5 US children. Existing prevention measures have had inadequate impact, while clinical management faces ongoing challenges with access, cost, tolerability, and chronicity of use. The authors state that no single intervention is sufficient, calling for coordinated actions across policy, health systems, and research alongside pharmacological therapies. Online version: https://www.diabesityrounds.com/a/jama-summit-report-outlines-multilevel-strategy-for-obesity-care-and-prevention
Authors
- Diabesity Rounds
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24361223
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00